Amid the reality of ever shrinking pipelines, strong project management has become a mainstay of good PPM decision making. Gain strategic, as well operational, insights into the latest trends and practices from top-tier industry experts at the 4th annual Pharma PPM Toolbox.

Building on their expertise, EBCG strives to provide you with the best possible platform for sharing PPM topics exclusively focused on the pharmaceutical industry. Our track record in developing such platforms speaks for itself. Consider what attendees of the most recent Pharma PPM Toolbox series had to say on the matter:

“One of the best conferences I have ever attended – very interesting and stimulating presentations, and -discussions, and excellent networking opportunities as well.”

Head of R&D Project Management Late Stage at Boehringer Ingelheim

“I enjoyed the meeting pretty much. It provided me a good insight into other companies’ project management organizations and gave me some new ideas to improve our work.”

R&D Project Leaderat Boehringer Ingelheim

“Congratulations on bringing together such a large group of professionals. You have managed to balance topics related to project management & planning vs. portfolio management very well. “

Head of Portfolio Management& Reporting at Sanofi Aventis

“A very good program covering a wide variety of topics all of which were relevant.”

Director, Biopharm Managementat Novo Nordisk

Tel.: +421 2 3220 2200 Fax: +421 2 3220 2222

ppm@ebcg.bizwww.ebcg.biz

4 Ways to contact us:

* 10 Professional Development Units B category can be claimed with the Project Management Institute(supported by a certificate of attendance issued by EBCG)

Who can you expect to meet?Project Portfolio Directors, R&D Directors, Program Directors,Project Leaders, Senior Project Team Members, Brand DirectorsLine Function Managers in: Project and Portfolio Management,Global R&D, Strategic Planning, Global Program, Portfolio Planning,Development Finance and Strategic SourcingFrom EMEA region

NetworkingopportunitiesEvening Cocktail ReceptionFavourite Coffee SpotFocused Panel Discussions & Breakout Sessions

Silver Sponsors:

Gold Sponsor:

http://ebcg.biz/ebcg-business-events/53/2014-pharma-ppm-toolbox/http://ebcg.biz/ebcg-business-events/53/2014-pharma-ppm-toolbox/

Nu

mb

er o

f Del

egat

es

2014 - prediction

2011 2012 2013 2014

60+

80+

100+

Annual Growth

Watch our video from2013 Pharma PPM Toolbox!

130+

Or feel free to ask on possible combinations and enhance your participation by choosing one day from the collocated training.The two day training is designed to give attendees of the Toolbox conference an additional full-day of professional development:

Peter WittnerSenior Consultant INTERPHARMConsultancy

Biosimilars – Understanding the Regulatory Processes and the Commercial Realities

19th March 2014 - Workshop

Anthony ElleryPresident, Former Global HeadLCM in Portfolio Managementat Novartis Ellery Pharma Consulting

Lifecycle Management

19th & 20th March 2014 - Collocated Training

n Regulatory, legal, scientific, medical, technical and commercial options for optimizing the brand life cycle, from early development through to the post-patent afterlifen What are the sustainable options in an ever-tightening cost-containing environment?n Options for a compelling, brand-specific, integrated LCM Plan

click here for more information

Biosimilars, biogenerics, follow-on biologicals and their potentialn What are we actually talking about?n Summary of issues affecting Biosimilars (regulatory, legal/IP, commercial)n Interchangeability – what is the issue?

The regulatory process and its pitfallsn Europe – a straight forward case (EMEA guidelines, successful and failed applications)n USA – how will the new legislation work out?n Japan compared to EU or USn Situation in other markets

Biosimilars – the commercial realityn What is the big attraction? Biologicals market and prospects; potential Biosimilars marketn What has happened so far?n Patents, IP and other issues (differing national legislation)n Where do Biosimilars go from here?

REGIsTRATION & COFFEE

WELCOME & INTRODUCTION

13.30

14.00

COFFEE & NETWORKING15.45

END OF WORKsHOP17.45

JOINED NETWORKING COCKTAIL RECEPTION18.00

14.10

14.45

16.15 Attendees of the Biosimilars Workshop and Lifecycle Management Training arecordially invited to a networking reception. Follow up on discussions started during the day, and enjoy fine snacks with the delicious drinks!

SIMPly, havEa GooD tIME!

http://events.ebcg.biz/pharma-lcm/%3Futm_source%3Dagenda%26utm_medium%3Dbanner%26utm_campaign%3Dppmagenda

Hartmut HeinDirector, Head of GlobalPlanning OfficeMerck Serono

Paolo MazzoniCEOPTM Consulting

Christine DeuschelVP Portfolio and Project ManagementDebiopharm

Gerrit BuurmanPrincipalCatenion

Hans-JurgenFederselSenior Principal Scientist,PhD, Assoc ProfessorAstra Zeneca

ReGiSTRATion & CoFFee8.30

oPeninG ReMARkS FRoM THe CHAiR9.00

SPeeD neTwoRkinG 9.10

STRATEGIC PHARMA PPM9.20

MoRninG CoFFee & neTwoRkinG10.30

LunCHeon FoLLoweD By CoFFee AnD neTwoRkinG13.00

CASe STuDy: PPM Introduction to the Project Evaluation11.00

n From the Start-up to the Big Pharma companies. How to measure the complexity with the same criteria (and have success) n Step by step methodology using Stage and Gate approachn Objective evaluation for strategic decision: Introducing MRL model n Data manipulation in a scientific environment. Bayesian Statistic and Expert Elicitation Modeln Q&A

PReSenTATion: Portfolio Drivers: Bringing all the Elements Together11.40

n Portfolio decisions based on sound datan The review process and follow up n Portfolio performance tips, or how to avoid late-stage attritionn Q&A

9.50 PReSenTATion: How to Implement Integrated R&D Operation

keynoTe PReSenTATion: Facing Strong Headwinds – Pharma Under Pressureto Define a Sustainable Future

n The historical legacy leading up to industry’s current experience of harsh realitiesn What countermeasures can be taken to prevent further decline?n Is a prosperous future possible and will industry achieve sustainability?n Q&A

n Convincing senior management n Evaluation of the right partner n Start implementation of integrated Planning and Business Operationsn Q&A

PReSenTATion: Portfolio Management for Early Stage Assets 12.20

n Context for R&D Decision Making, n Project Level Decision Making for Early Stage Assets,n Portfolio Level Decision Makingn Q&A

We cordially invite you to a networking reception. Meet your peers,continue in discussions, and enjoy fine snacks with the delicious drinks.

CLoSinG ReMARkS FRoM THe CHAiR18.10

AFTeRnoon CoFFee & neTwoRkinG15.50

neTwoRkinG CoCkTAiL ReCePTion 18.30

14.30 CASe STuDy: Navigating through the Regulatory Changes in Europen Increase your portfolio value for patients by benefiting from the new process of Parallel Scientific Advice with CHMP and Health Technology Assessment bodiesn Q&A

17.00 PReSenTATion: Resourcing Pharma Projects for Improved Outcomesn TBA n Q&A

17.40 PAneL DiSCuSSion: Changing the Blueprint of Pharman Balancing scientific and commercial risk in the pursuit of relevancen Innovative internal structures, M&A, collaborations with VCs, academic institutions, government grantsn New sources of innovation, and the challenges they bear for the R&D and commercial teamsn Macro or micro? Should the pharma industry be looking more at personalised medicine rather than concentrating on “one-size-fits-all” blockbusters?n Q&A

15.10 PReSenTATion: Late Stage Brands – Should you Invest?n When brands go off-patentn When is the time to stop investingn Q&A

TRENDS AND FORECASTS

SIMPLy, HAvE A gOOD TIME!

emmanuel FaureDirector GlobalRegulatory Affairsnovartis

Holger MüllerSVP CommercialOperationsCell Medica

Pasi PiitulainenSenior Director, Clinical Development Finance and Strategic SourcingActelion

Mary ellen yarossiRegional Director EMEAindependent Project Analysis

CASe STuDy: The Benefits and Shortfalls of Outsourcing16.20

n Why are companies outsourcingn Outsourcing as a strategic tooln Mini Case: Defining the outsourcing strategyn Q&A

Christine DeuschelVP Portfolio and Project ManagementDebiopharm

Peter wittnerSenior ConsultantinTeRPHARMConsultancy

Hans-Jurgen FederselSenior Principal Scientist,PhD, Assoc ProfessorAstra Zeneca

(TBA)

11.20 CASe STuDy: Spotting Project Errorsn Avoiding project failuresn Seeing the warning signs early onn The swan song: terminating the projectn Q&A

CASe STuDy: Holistic Portfolio Review at Bayer

n Quantitative and qualitative assessmentn Review process, project team input and management alignmentn Strategic and operational prioritiesn Q&A

12.00 CASe STuDy: Project Leadership Competencies:Separating Fact from Fiction

n Project leadership competencies: fictions!n Data gathered from EU and USA based research on project leadershipn Project leadership competencies: facts!n Implications for the development of highly capable project leadership in the life science industriesn Building the needed competencies: no gain without painn Q&A

12.00

Track A Morning Track B Morning

PROJECT MANAGEMENT EXCELLENCE RISK MANAGEMENT TIPS

MoRninG CoFFee & neTwoRkinG10.30

Marie BernasconiGlobal Program Directornovartis

Alessio MerlinSenior Portfolio Strategist, Director of ProjectManagement Office, Bayer

Pete HarpumClient Director, Mannaz

11.20 PReSenTATion: Steering a Steady Course throughthe Seas of Change

n Maintaining alignment of the project teamn Managing motivation within the project teamn Enhancing team unityn Q&A

Christoph HüstebeckHead of Project & Portfolio ManagementAbbott, established Pharmaceuticals

9.10

9.50

keynoTe PReSenTATion: Strategic Monitoring of Project Progress

PReSenTATion: Being a Successful Project Leader

n Monitoring activities and performancen Implementing project control and reporting systemsn Best tools and means of communicationn Q&A

n Lessons Learned: Today’s required Skills & Competenciesn Project Lead at different levels (dedicated PM vs. functional PM)n Responsibilities & Authority (Being a Leader vs. Being a Co-ordinator)n Accepting different Leadership Stylesn Q&A

oPeninG ReMARkS FRoM THe CHAiR9.00

LunCHeon FoLLoweD By CoFFee AnD neTwoRkinG12.40

Margaret McnaullDirector, Clinical DevelopmentAstra Zeneca

14.40 14.40

14.00 14.00CASe STuDy: Companion Diagnostics - Aligning Diagnostic and Pharmaceutical DevelopmentProcesses via Project and Portfolio Management

Portfolio Management Best Practices

Project Team Dynamics

Challenges Facing Pharma R&D

n Companion diagnostics - RPD’s vision & strategyn The diagnostic assay development and its interfaceto pharmaceutical developmentn Project and portfolio planning, monitoring, and steering - team building, processes, challenges & outlook n Q&A

n Dealing with challengesn Reducing late-stage pipeline attritionn Post-patent management of your brandsn Q&A

n Managing motivation, conflict & changen Open and clear communication of common goalsn Enhancing team unityn Q&A

n Regulatory changes affecting portfoliosn Rare diseases, Biologics or LCM, Biosimilars? What else is there?n Balancing the views of stakeholders, regulators and patients n Q&A

CLoSinG ReMARkS FRoM THe CHAiR16.40

Barbora ŠkvarkováProduction Manager, EBCg

I would like to thank to everyone who has helped with the organization of this event.A special thank you goes to the speakers and expert advisors for their support and commitment.

Enjoy the opportunity to discuss your current issues in a focused breakout session,and join the experts in leading a detailed exchange of ideas in an intimate group setting.

BReAkouT SeSSionS15.50

Discussion lead by:

Discussion lead by:

Gerrit BuurmanPrincipalCatenion

Margaret McnaullDirector, Clinical DevelopmentAstra Zeneca

Success Factors in Project Selection

n Keys for decision making in the limited resources environment n Management and balance of cost & resourcen Q&A

Discussion lead by:

nicoleta ButoescuPortfolio Program Manager EMEAPGT HealthcareTeva Pharmaceuticals

PReSenTATion: Finding Relevant Metrics for True Project Comparisons (TBC)

n Early vs. late stage projectsn Estimating the probability of successn Strategic outlook vs. negative NPVn Is there a magic formula for optimal solutions?n Q&A

PAneL DiSCuSSion: Handling Risk for Individual Project

PAneL DiSCuSSion: The Right Setup for Delivering the Right Outcome

n Assessing the value by non-financial methodsn Prioritization and achieving buy-in from the board

n Which organizational structure holds the key to optimal reporting channels as well as the best means of communication?n Aligning changes from outsourcing, merging, restructuring and other alternativesn Factors for operational excellence – are they case sensitive? Proven tools and strategies from different companies

Regina kraeuterProject Leader CDxRoche Diagnostics

AFTeRnoon CoFFee AnD SnACkS15.20

Monika Baudler-klein (TBC)TA Lead Pipeline and Portfolio Planning CNSand Metabolism, Roche Pharmaceuticals

Gold Sponsor

Silver Sponsors

Catenion is a management consulting firm devoted to helping pharmaceutical and medical products companies create more innovative and effective strategies and organisations and significantly increase their returns on R&D. We greatly improve how our clients assess the value and risk of their project and product portfolios and how they allocate resources. We also address the cultural impediments to pharmaceutical innovation by helping clients create the organisational climates that foster creativity and medical breakthroughs.

Achieving business value through project execution.Driving innovation and handling complexity are focal areas in the search for value creation. In the companies which are involved in delivering highly innovative projects, success is directly linked with an organisation-wide acceptance of what is needed to manage complexity: a genuine focus on creating structures and competences that strengthen the project leader’s ability to manage complex projects. Mannaz collaborative solutions focus on Project Leadership, Project Management, and Portfolio and Programme Management. We work with the world’s leading companies because of our ability to create immediate and measurable impact and our experiences in developing leaders across the world. Adopting innovative and efficient learning methods, we empower people performance and business success. See more at: www.mannaz.comMannaz’ Dr. Pete Harpum will be presenting his research at the conference.

For more than 20 years, Campana & Schott has been successfully working in the fields of Project Management and Social Collaboration. As a Project Management consulting firm, Campana& Schott is an experienced and competent partner for all project matters: management of large projects, optimization of PM processes, introduction of PM systems, structuring of PM offices or qualification/ certification of employees. In optimizing Social Collaboration between people, Campana& Schott provides well-founded expertise and long-standing practical experience. With an established combination of management consulting, technology consulting, strategy realization and its own software products, Campana& Schott is an international group of companies working mainly for multinational companies of all industries.

The story of PTM Consulting officially starts about ten years ago but the story of people in, times before. PTM Consulting supports Life Sciences companies aiming in Project Portfolio Management his main challenge and involving skilled resources and investments. Experience, knowledge competence and organization are the values that lead the company ahead in the future. PTM ‘s people follow the continuous improvement as method to anticipate innovation. PTM sound is robust and affordable. We concentrate our attention on the customer needs to turn business in partnership and became the added value which take the project to the full success.

1. Raise your profile and position yourself as an international product leader who stays on top of major current and future trends with full visibility in a venue designed exclusively for the Pharma industry.

2. Experience two full days of unprecedented networking opportunities with key regional decision makers in an intimate environment of a strictly enforced and highly favourable end-user to vendor ratio.

3. Achieve unparalleled face-to-face time with potential new customers in that same networking environment.

4. Take advantage of tailor made sponsorship packages that allow you to competitively position your brand and increase awareness of your product or service within your target market

For sponsorship info contact: zornitsa.velikova@ebcg.biz

4 Reasons You Should Sponsor the 4th Annual Pharma PPM Toolbox

Media Partners